Senseonics is a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its first generation continuous glucose monitoring, or CGM, system is a reliable, long-term, implantable CGM system that the Company has designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 days, as compared to five to seven days for currently available CGM systems.

Company Growth (employees)
Germantown, US
Size (employees)
76 (est)+2%
Senseonics was founded in 1996 and is headquartered in Germantown, US

Key People at Senseonics

Timothy T. Goodnow

Timothy T. Goodnow

President & CEO
Mukul Jain

Mukul Jain


Senseonics Office Locations

Senseonics has an office in Germantown
Germantown, US (HQ)
20451 Seneca Meadows Parkway

Senseonics Data and Metrics

Senseonics Financial Metrics

Numbers are in $, USD

Market capitalization (22-Jun-2017)

247.6 m

Closing share price (22-Jun-2017)

Senseonics's current market capitalization is $247.6 m.

Senseonics Market Value History

Senseonics Job Categories

Senseonics Company Life and Culture

You may also be interested in